Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Heat Biologics Inc (HTBX)

Heat Biologics Inc (HTBX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 158,985
  • Shares Outstanding, K 25,397
  • Annual Sales, $ 2,950 K
  • Annual Income, $ -26,050 K
  • 60-Month Beta 0.44
  • Price/Sales 52.72
  • Price/Cash Flow N/A
  • Price/Book 1.27
Trade HTBX with:

Options Overview

Details
  • Implied Volatility 91.20%
  • Historical Volatility 53.80%
  • IV Percentile 17%
  • IV Rank 11.31%
  • IV High 218.07% on 06/10/21
  • IV Low 75.03% on 08/18/21
  • Put/Call Vol Ratio 0.10
  • Today's Volume 459
  • Volume Avg (30-Day) 435
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 5,357
  • Open Int (30-Day) 5,524

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.29
  • Number of Estimates 3
  • High Estimate -0.27
  • Low Estimate -0.31
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +30.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.02 +3.99%
on 09/15/21
7.63 -18.00%
on 09/02/21
-0.01 (-0.16%)
since 08/16/21
3-Month
5.96 +5.03%
on 07/19/21
7.63 -18.00%
on 09/02/21
-0.75 (-10.70%)
since 06/16/21
52-Week
5.22 +19.92%
on 01/04/21
17.00 -63.18%
on 02/09/21
-3.40 (-35.20%)
since 09/16/20

Most Recent Stories

More News
Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th

Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Jeff Wolf, Chief Executive...

HTBX : 6.26 (+2.29%)
Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Jeff Wolf, Chief Executive...

HTBX : 6.26 (+2.29%)
Heat Biologics to Provide Corporate Update

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced CEO Jeff Wolf will...

HTBX : 6.26 (+2.29%)
Heat Biologics Unveils Skunkworx Bio, New Drug Discovery Subsidiary

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced the launch of its...

HTBX : 6.26 (+2.29%)
Heat Biologics Announces Addition of Former US Senator Mark Pryor to Biothreat Advisory Board

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, announces the addition of Mark Pryor,...

HTBX : 6.26 (+2.29%)
Heat Biologics Announces New Additions to Biothreat Advisory Board

Former Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs, Andrew C. Weber

HTBX : 6.26 (+2.29%)
Heat Biologics Announces Formation of Biothreat Advisory Board

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, announces it has commenced development...

HTBX : 6.26 (+2.29%)
Heat Biologics Provides Second Quarter 2021 Business Update

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today provided financial, clinical...

HTBX : 6.26 (+2.29%)
Heat Biologics Announces Groundbreaking for New San Antonio Facility

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced it will be hosting...

HTBX : 6.26 (+2.29%)
Heat Biologics Joins Russell Microcap(R) Index

Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that it has been added to the...

HTBX : 6.26 (+2.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company's products under development include HS-110 for the treatment of non-small cell...

See More

Key Turning Points

3rd Resistance Point 6.75
2nd Resistance Point 6.57
1st Resistance Point 6.41
Last Price 6.26
1st Support Level 6.07
2nd Support Level 5.89
3rd Support Level 5.73

See More

52-Week High 17.00
Fibonacci 61.8% 12.50
Fibonacci 50% 11.11
Fibonacci 38.2% 9.72
Last Price 6.26
52-Week Low 5.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar